Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria Vaccines | 9 | 2013 | 21 | 2.730 |
Why?
|
| Merozoite Surface Protein 1 | 12 | 2012 | 34 | 2.670 |
Why?
|
| Antibodies, Protozoan | 12 | 2013 | 82 | 1.920 |
Why?
|
| Plasmodium falciparum | 11 | 2011 | 144 | 1.900 |
Why?
|
| Adjuvants, Immunologic | 6 | 2011 | 117 | 1.070 |
Why?
|
| Malaria, Falciparum | 4 | 2011 | 90 | 0.950 |
Why?
|
| Immunization | 4 | 2013 | 94 | 0.630 |
Why?
|
| Malaria | 3 | 2013 | 90 | 0.600 |
Why?
|
| Nanoparticles | 2 | 2012 | 460 | 0.490 |
Why?
|
| Peptide Fragments | 4 | 2006 | 307 | 0.470 |
Why?
|
| Vaccines, Synthetic | 5 | 2012 | 80 | 0.440 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2013 | 60 | 0.440 |
Why?
|
| Subtilisins | 1 | 2013 | 12 | 0.410 |
Why?
|
| Rabbits | 6 | 2013 | 278 | 0.380 |
Why?
|
| Ferric Compounds | 1 | 2012 | 62 | 0.370 |
Why?
|
| Mice | 11 | 2025 | 6644 | 0.350 |
Why?
|
| Protein Precursors | 2 | 2025 | 59 | 0.350 |
Why?
|
| Fellowships and Scholarships | 1 | 2011 | 32 | 0.350 |
Why?
|
| Biomedical Research | 2 | 2020 | 502 | 0.340 |
Why?
|
| Minority Groups | 2 | 2020 | 690 | 0.340 |
Why?
|
| Drug Carriers | 1 | 2012 | 174 | 0.340 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 458 | 0.340 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 120 | 0.330 |
Why?
|
| Animals | 16 | 2025 | 16992 | 0.300 |
Why?
|
| Lipid A | 1 | 2008 | 8 | 0.290 |
Why?
|
| Mice, Knockout | 6 | 2019 | 1035 | 0.270 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 59 | 0.270 |
Why?
|
| Immune Sera | 1 | 2006 | 56 | 0.260 |
Why?
|
| Students | 2 | 2020 | 626 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 1869 | 0.250 |
Why?
|
| Interleukin-6 | 1 | 2007 | 165 | 0.250 |
Why?
|
| Thymosin | 1 | 2025 | 3 | 0.230 |
Why?
|
| Deer | 1 | 2025 | 16 | 0.230 |
Why?
|
| Gene Expression | 2 | 2025 | 701 | 0.220 |
Why?
|
| Antigens, Protozoan | 3 | 2007 | 74 | 0.190 |
Why?
|
| Recombinant Proteins | 4 | 2025 | 518 | 0.190 |
Why?
|
| Dendritic Cells | 2 | 2012 | 132 | 0.170 |
Why?
|
| Interleukin-4 | 3 | 2008 | 75 | 0.170 |
Why?
|
| Interferon-gamma | 3 | 2008 | 269 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 1180 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 3 | 2008 | 694 | 0.150 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 1542 | 0.150 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 13 | 0.150 |
Why?
|
| Colitis | 1 | 2019 | 71 | 0.140 |
Why?
|
| Cultural Diversity | 1 | 2020 | 193 | 0.140 |
Why?
|
| Cytokines | 2 | 2012 | 678 | 0.140 |
Why?
|
| Immunoglobulin G | 2 | 2011 | 259 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 165 | 0.140 |
Why?
|
| Female | 8 | 2020 | 24698 | 0.130 |
Why?
|
| Hotlines | 1 | 2017 | 16 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 14 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 223 | 0.120 |
Why?
|
| Immunodominant Epitopes | 1 | 1996 | 29 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 1996 | 52 | 0.120 |
Why?
|
| Cell Line | 3 | 2025 | 1410 | 0.120 |
Why?
|
| Vaccination | 1 | 1998 | 355 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 1996 | 189 | 0.110 |
Why?
|
| Schools | 2 | 2020 | 283 | 0.110 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2008 | 16 | 0.110 |
Why?
|
| Protozoan Proteins | 1 | 1996 | 191 | 0.110 |
Why?
|
| Aotidae | 1 | 2012 | 4 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2013 | 272 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 47 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 197 | 0.090 |
Why?
|
| Humans | 7 | 2020 | 43102 | 0.090 |
Why?
|
| Quantum Dots | 1 | 2011 | 38 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 267 | 0.090 |
Why?
|
| Alleles | 2 | 2006 | 352 | 0.080 |
Why?
|
| Minority Health | 1 | 2011 | 95 | 0.080 |
Why?
|
| Hawaii | 2 | 2017 | 2011 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 529 | 0.070 |
Why?
|
| Emulsions | 1 | 2008 | 36 | 0.070 |
Why?
|
| STAT6 Transcription Factor | 1 | 2008 | 17 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2007 | 25 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2007 | 76 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 2007 | 39 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 97 | 0.070 |
Why?
|
| Spleen | 1 | 2007 | 204 | 0.060 |
Why?
|
| Antibodies, Blocking | 1 | 2006 | 11 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 39 | 0.060 |
Why?
|
| Antibody Specificity | 1 | 2006 | 76 | 0.060 |
Why?
|
| Vaccines, Subunit | 1 | 2006 | 34 | 0.060 |
Why?
|
| Epitopes | 1 | 2006 | 157 | 0.060 |
Why?
|
| United States | 2 | 2020 | 5205 | 0.060 |
Why?
|
| Adolescent | 2 | 2020 | 6081 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2025 | 314 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2025 | 460 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2002 | 165 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 185 | 0.040 |
Why?
|
| Male | 3 | 2020 | 23409 | 0.040 |
Why?
|
| Interleukin-16 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 59 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1455 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 147 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 211 | 0.040 |
Why?
|
| Mentors | 1 | 2020 | 145 | 0.040 |
Why?
|
| Species Specificity | 1 | 1998 | 286 | 0.030 |
Why?
|
| Liposomes | 1 | 1998 | 132 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 611 | 0.030 |
Why?
|
| Pacific Ocean | 1 | 2017 | 13 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 934 | 0.030 |
Why?
|
| Aotus trivirgatus | 1 | 1996 | 1 | 0.030 |
Why?
|
| Protozoan Vaccines | 1 | 1996 | 16 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1996 | 109 | 0.030 |
Why?
|
| Universities | 1 | 2020 | 559 | 0.030 |
Why?
|
| Research | 1 | 2017 | 181 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1996 | 430 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1596 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 968 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 2157 | 0.020 |
Why?
|
| Bombyx | 1 | 2002 | 2 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 52 | 0.010 |
Why?
|
| Larva | 1 | 2002 | 133 | 0.010 |
Why?
|